Answers are grounded in this paper and cite their sources.
SUMMARY Six calves were inoculated intranasally with a vaccinal strain of infectious bovine rhinotracheitis (ibr) virus, and six calves were given a placebo. All calves were challenge exposed (aerosol) with a bovine rhinovirus 4 days later. Nasal excretion of ibr virus and rhinovirus, interferon concentrations in the nasal secretions (ns), and serum antibody were measured before, and at times after, calves were inoculated. All calves given ibr virus had detectable interferon in their ns. Four of the calves had interferon in their ns at 24 hours after ibr viral inoculation. All six calves had interferon at 2, 4, and 5 days, and 5 calves continued to have interferon in their ns at 7 days after ibr viral inoculation. Nasal excretion of ibr virus usually persisted longer than did secretion of interferon. Interferon was not detected in the ns of control calves after challenge exposure with rhinovirus. Serum interferon was not detected in any calf. After rhinovirus challenge, nasal excretion of rhinovirus was detected only one time in one calf given ibr virus. In contrast, rhinovirus excretion was detected in five control calves on at least two consecutive days. Excretion of rhinovirus was detected in 3 control calves at 6 days, in 2 calves at 10 days, and 1 calf at 14 days after rhinovirus inoculation. Clinical signs of respiratory tract disease were not observed in control calves excreting rhinovirus. All of the 12 calves in the experiment had serum antibody against rhinovirus at the time of challenge exposure, but this antibody did not protect against infection of the controls as evidenced by rhinovirus excretion in the ns.
No takes yet. Share an insight, caveat, or question.
Cummins et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: